Fanglin Yu Selected Research

Fanglin Yu Research Topics

Disease

7	Acute Kidney Injury (Acute Renal Failure) 12/2024 - 07/2022
7	Neoplasms (Cancer) 01/2021 - 01/2016
4	Bites and Stings (Sting) 12/2023 - 08/2022
3	Rhabdomyolysis 01/2023 - 08/2022
3	Hemolysis 01/2023 - 08/2022
1	Inflammation (Inflammations) 12/2023
1	Renal Insufficiency (Renal Failure) 12/2023
1	Oliguria 07/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Postoperative Pain 01/2019
1	Pain (Aches) 01/2019
1	Glioma (Gliomas) 11/2017
1	Hypertension (High Blood Pressure) 10/2017

Drug/Important Bio-Agent (IBA)

5	Wasp Venoms (Venom, Wasp)IBA 12/2024 - 07/2022
3	MyoglobinIBA 07/2023 - 07/2022
3	Liposomes (Liposome)IBA 11/2017 - 01/2016
2	VenomsIBA 12/2023 - 07/2022
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 07/2022
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022 - 07/2022
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2022 - 07/2022
2	Vincristine (Oncovin)FDA LinkGeneric 11/2017 - 10/2017
2	Peptides (Polypeptides)IBA 11/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 09/2017 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	NLR ProteinsIBA 12/2023
1	NucleotidesIBA 12/2023
1	InterferonsIBA 12/2023
1	Glycerol (Glycerine)FDA LinkGeneric 12/2022
1	Cilastatin FDA Link 12/2022
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 12/2022
1	varespladibIBA 08/2022
1	PLIalphaIBA 08/2022
1	Phospholipases A2 (Phospholipase A2)IBA 08/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	CreatinineIBA 07/2022
1	ErbB Receptors (EGF Receptor)IBA 05/2022
1	Immune Checkpoint InhibitorsIBA 05/2022
1	B7-H1 AntigenIBA 05/2022
1	Programmed Cell Death 1 ReceptorIBA 05/2022
1	Albumin-Bound Paclitaxel FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	QuercetinIBA 04/2019
1	Local AnestheticsIBA 01/2019
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 11/2017
1	LigandsIBA 11/2017
1	CY5.5 cyanine dyeIBA 10/2017
1	Valsartan (Vals)FDA Link 10/2017
1	Metolazone (Diulo)FDA LinkGeneric 10/2017
1	ChitosanIBA 09/2017
1	SolutionsIBA 01/2017
1	Poloxamer (Poloxamer 407)IBA 01/2016
1	PolymersIBA 01/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016

Therapy/Procedure

3	Therapeutics 10/2017 - 01/2016
1	Subcutaneous Injections 07/2022
1	Analgesia 01/2019
1	Microspheres (Microsphere) 01/2019